S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NYSE:CST

CST Brands (CST) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$48.53
$48.53
50-Day Range
N/A
52-Week Range
$40.85
$48.56
Volume
N/A
Average Volume
488,300 shs
Market Capitalization
N/A
P/E Ratio
14.49
Dividend Yield
N/A
Price Target
N/A
CST stock logo

About CST Brands Stock (NYSE:CST)

CST Brands LLC, formerly CST Brands, Inc., is a holding company. The Company is an independent retail of motor fuel and convenience merchandise in the United States and eastern Canada. Its segments include U.S. Retail, Canadian Retail and CrossAmerica. As of December 31, 2016, its U.S. Retail segment had 1,167 Company-operated retail sites located in Arkansas, Arizona, Colorado, Florida, Georgia, Louisiana, New Mexico, New York, Oklahoma and Texas. As of December 31, 2016, its Canadian Retail segment had 884 retail sites located in New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Prince Edward Island and Quebec. As of December 31, 2016, its CrossAmerica segment had 1,187 distribution sites located in 29 states, which consisted of 403 independent dealer sites, 153 sites operated by Dunne Manning Stores LLC, 420 sites operated by lessee dealers, 95 commission sites, 73 CrossAmerica Partners LP Company-operated retail sites and 43 CST Company-operated retail sites.

CST Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Solar eclipse 2024: Live updates from Chicago and beyond
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Migrants sheltering at 5 city parks to be moved
See More Headlines
Receive CST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CST Brands and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/05/2016
Today
4/19/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Automotive Retail
CUSIP
12646R10
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Darrell Davis
    President, Senior Vice President - Operations , Director
  • Kimberly S. Lubel (Age 52)
    Chief Executive Officer
  • Clayton E. Killinger (Age 56)
    Chief Financial Officer, Executive Vice President
  • Charles Hal Adams (Age 57)
    President - Retail Operations
  • Anthony P. Bartys (Age 60)
    Senior Vice President and Chief Operating Officer
  • Gerard J. Sonnier (Age 58)
    Senior Vice President, General Counsel, Corporate Secretary
  • Steven M. Stellato (Age 42)
    Vice President, Controller
  • Kathy Cunnington
    Vice President - Shared Services, Treasurer, Secretary

CST Stock Analysis - Frequently Asked Questions

How were CST Brands' earnings last quarter?

CST Brands, Inc. (NYSE:CST) posted its earnings results on Friday, August, 5th. The specialty retailer reported $0.39 earnings per share for the quarter, missing the consensus estimate of $0.43 by $0.04. The specialty retailer had revenue of $2.52 billion for the quarter, compared to the consensus estimate of $2.57 billion. CST Brands's revenue was down 1.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.31 EPS.

Is CST Brands a good dividend stock?

CST Brands (NYSE:CST) pays an annual dividend of $0.06 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 1.79%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for CST.

What other stocks do shareholders of CST Brands own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CST Brands investors own include Valero Energy (VLO), Fidelity National Information Services (FIS), Energy Transfer (ET), Coca-Cola (KO), CrossAmerica Partners (CAPL), Alcoa (AA), Cisco Systems (CSCO), General Electric (GE), Intel (INTC) and Twitter (TWTR).

This page (NYSE:CST) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners